September 8, 2015
September 8, 2015 —
Using “mini-brains” built with induced pluripotent stem cells derived from patients with a rare, but devastating, neurological disorder, researchers at University of California, San Diego School of Medicine say they have identified a drug candidate that appears to “rescue” dysfunctional cells by suppressing a critical genetic alteration.
September 3, 2015
September 3, 2015 —
Researchers at University of California, San Diego School of Medicine have documented the accuracy of three new tests for more rapidly diagnosing drug-resistant forms of tuberculosis (TB), which are much harder and more expensive to treat and which, experts say, represent a major threat to global public health.
September 3, 2015
September 3, 2015 —
In some patients, aggressive cancers can become resistant to chemotherapy and radiation treatments. In a paper published in the journal Nature Communications, University of California, San Diego School of Medicine researchers identified a pathway that causes the resistance and a new therapeutic drug that targets this pathway.
September 2, 2015
September 2, 2015 —
From comprehensive stroke care when every second counts to stitching deep cuts and evaluating flu symptoms, UC San Diego Health provides the highest quality of care when patients arrive through the emergency room doors. Now, as part of a long term partnership between UC San Diego Health and El Centro Regional Medical Center (ECRMC), patients in the Imperial Valley will receive the same specialty emergency care.
September 1, 2015
September 1, 2015 —
An international research team, headed by Joseph Vinetz, MD, professor of medicine at University of California, San Diego School of Medicine and director of the UC San Diego Center for Tropical Medicine and Travelers Health, has been awarded a 5-year, $1.89 million cooperative agreement to carry out translational research studies of leptospirosis, an infectious and sometimes fatal bacterial disease endemic in much of the world.
August 28, 2015
August 28, 2015 —
Four University of California, San Diego School of Medicine researchers have been selected to receive the newly established National Cancer Institute (NCI) Outstanding Investigator Award. The multi-million dollar awards fund new projects that have an unusual potential in cancer research over seven years.
August 27, 2015
August 27, 2015 —
Degenerating neurons in patients with Alzheimer’s disease (AD) measurably responded to an experimental gene therapy in which nerve growth factor (NGF) was injected into their brains, report researchers at University of California, San Diego School of Medicine in the current issue of JAMA Neurology.
August 24, 2015
August 24, 2015 —
Patty Maysent, MPH, MBA, has been appointed interim Chief Executive Officer of UC San Diego Health, bringing to the role more than 25 years of exceptional executive experience in hospital leadership and health services management.
August 18, 2015
August 18, 2015 —
The Clinical and Translational Research Institute (CTRI) at University of California, San Diego has received a five-year Clinical and Translational Science Award (CTSA) for approximately $52 million from the National Center for Advancing Translational Science, part of the National Institutes of Health.
August 17, 2015
August 17, 2015 —
The introduction of a new prescription smoking-cessation aid, varenicline, in 2006 has had no significant impact on the rate at which Americans age 18 and older successfully quit smoking, according to a study led by researchers at University of California, San Diego School of Medicine. The findings, published online August 17 in Tobacco Control, suggest that the primary effect of varenicline has been to displace the use of older tobacco addiction therapies, such as nicotine patches and the antidepressant, bupropion.
